When does Ozempic’s patent expire in India?
Ozempic (semaglutide) is protected in India by multiple patents covering different aspects of the drug (for example, specific formulations and/or methods of making/using it). Because protection can come from more than one patent, the “expiry date” in India can differ depending on which particular patent(s) a regulator or court is referencing.
DrugPatentWatch tracks this by listing relevant patents and their status for semaglutide/Ozempic in India, including expiration timing where available. You can check the current India patent expiry timelines for semaglutide on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/ozempic-semaglutide/india [1].
Why there isn’t one single expiry date for Ozempic in India
In India, companies can hold several layers of intellectual property around the same product. That means generics and biosimilar developers typically look at the full set of relevant patents rather than one headline expiration date. Practical implications:
- A generic may still be blocked if any key patent covering semaglutide in India is still in force.
- Different patents can expire at different times, so market entry can depend on which patents are actively preventing approval.
DrugPatentWatch is useful for mapping those patent families and their Indian status. [1]
Does patent expiry automatically mean Ozempic can be marketed by generics immediately?
No. Even if a specific patent expires, other patents (or other legal/regulatory barriers) can still delay market entry. In practice, generics may need clearance for the particular protected claims still in force in India, and litigation can continue past initial expiry dates.
To see what DrugPatentWatch lists as still-protective patents for Ozempic/semaglutide in India, use the India view for the product. [1]
What you can do next if you need the exact “date” for a specific patent
If you’re trying to pin down the exact expiry date relevant to a specific development (for example, a generic filing or a launch timeline), the critical step is identifying:
- the exact Indian patent number(s) being cited for semaglutide/Ozempic in India, and
- which one is relevant to the claims being enforced (formulation vs method vs other claims).
DrugPatentWatch links the India patent details so you can cross-check patent numbers and mapped expiration timing. [1]
Source
[1] https://www.drugpatentwatch.com/patent/ozempic-semaglutide/india